0001127602-15-006167.txt : 20150218 0001127602-15-006167.hdr.sgml : 20150216 20150217115847 ACCESSION NUMBER: 0001127602-15-006167 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150213 FILED AS OF DATE: 20150217 DATE AS OF CHANGE: 20150217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAREXEL INTERNATIONAL CORP CENTRAL INDEX KEY: 0000799729 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 042776269 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 195 WEST ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7814879900 MAIL ADDRESS: STREET 1: 195 WEST ST CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VON RICKENBACH JOSEF H CENTRAL INDEX KEY: 0001007706 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21244 FILM NUMBER: 15619692 MAIL ADDRESS: STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION CITY: WALTHAM STATE: MA ZIP: 02451-1163 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-02-13 0000799729 PAREXEL INTERNATIONAL CORP PRXL 0001007706 VON RICKENBACH JOSEF H PAREXEL INTERNATIONAL CORPORATION 195 WEST STREET WALTHAM MA 02451 1 1 Chairman & CEO Common Stock 2015-02-13 4 M 0 100000 30.18 A 651806 D Common Stock 2015-02-13 4 M 0 34650 21.97 A 686456 D Common Stock 2015-02-13 4 M 0 37925 20.26 A 724381 D Common Stock 2015-02-13 4 F 0 117098 63.09 D 607283 D Common Stock 2015-02-13 4 S 0 61000 62.49 D 546283 D Common Stock 2015-02-13 4 S 0 4100 63.11 D 542183 D Stock Option (Right to Buy) 30.18 2015-02-13 4 M 0 100000 0 D 2016-09-11 Common Stock 100000 0 D Stock Option (Right to Buy) 21.97 2015-02-13 4 M 0 34650 0 D 2018-09-15 Common Stock 34650 0 D Stock Option (Right to Buy) 20.26 2015-02-13 4 M 0 37925 0 D 2019-09-21 Common Stock 37925 37925 D Includes 240 shares of common stock acquired pursuant to the Issuer's 2000 Employee Stock Purchase Plan. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $62.00-$62.99. The price reported in this column reflects the weighted average sales price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price, upon request. This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $63.00-$63.30. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price. Currently exercisable Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant. /s/Douglas A. Batt, Attorney-In-Fact 2015-02-16